As Biogen grapples with coronavirus crisis, Big Pharmas like Eli Lilly, Takeda hunker down, tell staffers to work from home
With the number of coronavirus cases spiraling upwards over the weekend at Biogen, other biopharma companies are hunkering down and adding new precautionary measures …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.